Defibrillators Market, Size, Share

Comments · 109 Views

Global Defibrillator Market is foreseen to be priced at around US$ 20.84 Billion by 2030, according to Renub Research. In modern days, the defibrillator is a life-saving medical device designed to restore a standard coronary heart rhythm in people experiencing cardiac arrest or arrhythmia.

The global defibrillator market is projected to attain approximately US$ 20.84 Billion through 2030, with a forecasted CAGR of 7.20% from 2024 to 2030. By 2023, the market is expected to be worth US$12.8 Billion.

Defibrillators are essential lifestyle-saving gadgets used during cardiac arrest or arrhythmia to restore regular heart rhythm through defibrillation. Automated External Defibrillators (AEDs) are easily accessible in public spaces, consumer-friendly, and help bystanders with voice prompts and visible instructions, essential for growing survival rates earlier than expert help arrives in unexpected cardiac arrest instances. Cardiovascular diseases, along with cardiac arrest, claim 17.9 million lives yearly, making them the main global motive of death, as per World Heart Federation. As the populace ages, the demand for defibrillators in hospitals and public regions rises due to age-related cardiovascular dangers. Technological development and expanded public consciousness have boosted cardiac arrest survival costs, spurring defibrillator market growth. Defibrillators have advanced with smaller, lighter, and consumer friendly designs, making Public Access Defibrillators not unusual in public regions and home devices more reasonably priced. North America leads the defibrillator marketplace, pushed by high healthcare expenditure and recognition. Drone-introduced defibrillators provide fast useful resource in far off or congested locales. Future defibrillator improvements awareness on wearable tech, miniaturization, and more suitable tracking for rapid intervention. Implantable defibrillator studies aim to enhance capabilities and lifespan, revolutionizing cardiac take care of high-threat patients.

Global Defibrillator Market segment

Implantable defibrillators, poised for marketplace leadership, reveal coronary heart rhythm constantly and supply lifestyles-saving shocks when irregularities occur. Demand is fueled by growing cardiovascular diseases and technological progress. Ongoing research targets more desirable features and longer device lifespans for high-chance sufferers, bolstering reliability. With advanced affected person outcomes, they're pivotal in advancing global cardiac care. In December 2023, Medtronic delivered a unique implantable cardioverter defibrillator, the Aurora extravascular ICD. This tool is placed under the skin, in particular underneath the left armpit, departing from the conventional placement under the collarbone.

The hospital region is anticipated to steer the defibrillator marketplace as they require defibrillators for treating cardiac emergencies, making an investment in modern-day technology to deal with sudden cardiac arrest efficaciously. Being pivotal in healthcare, hospitals power innovation within the defibrillator market.

In the United States, 356,000 out-of-medical institution cardiac arrests occur every year, driving defibrillator demand. Strong recognition of cardiovascular diseases, sturdy healthcare infrastructure, and a growing old population fuel this demand. Rigorous research, favorable reimbursement regulations, and public access to defibrillators force marketplace boom, supported by stringent emergency response guidelines. The U.S. is a substantial force in advancing cardiac care globally. Favorable guidelines, sizeable company projects, and advanced healthcare infrastructure fueled United States market growth. In 2020, Boston Scientific's sale of 33,000 CRT-Ds, along with Resonate, Autogen, Dynagen, Incepta, and Cognis, with 16,500 in the U.S., highlights sizeable adoption. The CDC's September 2021 record found out 659,000 annual American deaths from heart disease and 805,000 heart attacks, 605,000 being first-time occurrences, riding market increase within the U.S.

Key Players in Global Defibrillator Market

Medtronic Plc, Boston Scientific Corporation, Philips Healthcare, Nihon Kohden Corporation, Asahi Kasei Corporation, Stryker Corporation, Abbott, and LivaNova PLC are prominent players in the global defibrillator market.

Product – Global Defibrillator Market breakup in 2 viewpoints:

  1. Implantable Defibrillators
  2. External Defibrillators

 

 

End-Users – Global Defibrillator Market breakup in 5 viewpoints:

  1. Hospital
  2. Pre-hospital
  3. Public Access Market
  4. Alternate Care Market
  5. Home Healthcare

 

Countries – Global Defibrillator Market breakup in 5 viewpoints:

  1. North America

1.1    United States

1.2    Canada

 

  1. Europe

2.1    France

2.2    Germany

2.3    Italy

2.4    Spain

2.5    United Kingdom

2.6    Belgium

2.7    Netherlands

2.8    Turkey

 

  1. Asia Pacific

 

3.1    China

3.2    Japan

3.3    India

3.4    South Korea

3.5    Thailand

3.6    Malaysia

3.7    Indonesia

3.8    Australia

3.9    New Zealand

 

  1. Latin America

 

4.1    Brazil

4.2    Mexico

4.3    Argentina

 

  1. Middle East Africa

 

5.1    Saudi Arabia

5.2    UAE

5.3    South Africa

 

 

All the Key players have been covered from 3 Viewpoints:

  • Overview
  • Recent Developments
  • Revenue Analysis

 

Company Analysis:

  1. Medtronic Plc
  2. Boston Scientific Corporation
  3. Philips Healthcare
  4. Nihon Kohden Corporation
  5. Asahi Kasei Corporation
  6. Stryker Corporation
  7. Abbott
  8. LivaNova PLC